|
|
News Breaks | | | | November 27, 2012 | | 09:13 EDT |  | VRTX | Vertex anti-flu treatment could interest investors, says Wells Fargo
Wells Fargo believes that investors are currently giving Vertex's flu treatment little or no value, but the firm thinks preclinical data indicates that the drug may be effective and have advantages over Tamiflu. The firm believes that investors may become interested in the long-term revenue potential of the drug, and it maintains an Outperform rating on the stock. | |
|
News For VRTX From The Last 14 Days Check below for free stories on VRTX the last two weeks. |
|
|
| May 10, 2013 | | 14:02 EDT | | VRTX | Vertex to benefit from Welsh government decision, says Wells Fargo
 Subscribe for More Information | |
|
|
|
|
|
|
